Needle-Free Injectors Market is expected to Reach US$ 42.79 Bn by Registering a CAGR of 12% in the forecast period 2022-2032 | Future Market Insights, Inc.
As per Future Market Insights, the U.S. is expected to be a leading market across North America, accounting for over 94.0% of the market in 2022. Germany is expected to dominate the Europe, holding 29.4% Europe’s market share through 2032. Japan is projected to hold over 34% share in the East Asia market, exhibiting growth at a CAGR of 11.7% during the forecast period
NEWARK, Del, Sept. 16, 2022 (GLOBE NEWSWIRE) -- A recently published study by FMI expects the global needle-free injectors market to augment at a 12% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 42.79 Billion is expected for the market. Faster drug delivery is the key driver for the needle-free injector market. Increasing demand for healthcare sector along with growth in cosmetic surgeries is driving the demand for needle-free injectors.From 2017 to 2021, the industry experienced noteworthy growth, registering a value CAGR of 8% and closing at US$ 12.3 Billion. The use of technologically advanced spring-loaded jet injectors is favoring the growth of the market. In addition, approvals from government authorities to maximize the use of needle-free injectors is accelerating the demand of the same.
*Request Sample @ *https://www.futuremarketinsights.com/reports/sample/rep-gb-13960
Geographically, U.S. is the largest contributor to the needle-free injectors market. This is owing to the growing prevalence of chronic diseases in the region. The strong presence of healthcare sectors in Germany, Japan and China too are accelerating the use of needle-free injectors. In the upcoming years, increasing inclination towards minimally invasive surgeries will increase the sales of needle-free injectors.
*Key Takeaways from the Market Study*
· By load type, the projectile injections segment is expected to expand at a *CAGR of 13.9%* during the forecast period.
· By technology, spring-loaded jet injector segment will dominate the market, holding *47.1%* of the revenue share in 2022.
· By application, drug delivery is expected to hold the leading share in the market, accounting for *65.0%* of the revenue share in 2022.
· With *79.5%* of the revenue share, reusable needle-free injectors are expected to dominate the market in 2022
· By end-user, hospitals are expected to be the primary end-user, accounting for over *33.4%* market share during the forecast period.
· U.S. is expected to be a leading market across North America, accounting for over *94.0%* of the market in 2022
· Germany is expected to dominate the Europe, holding *29.4% *Europe’s market share through 2032
· Japan is projected to hold *over 34%* share in the East Asia market, exhibiting growth at a CAGR of *11.7%* during the forecast period
· China led the East Asia market with more than *46.8%* share and is projected to expand at a CAGR of *12.0%* through 2032.
“The healthcare sector along with the cosmetic industry are the largest contributors to needle-free injectors market. Increasing demand for minimally-invasive surgeries is further accelerating the demand for needle-free injectors” states an FMI analyst
*Talk **to Analyst @* https://www.futuremarketinsights.com/ask-question/rep-gb-13960
*Market Competition*
Key players in the needle-free injectors market are Gerresheimer AG, Pfizer Inc., Antares Pharma, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation
· In August 2022, University of Adelaide began the human trail of omicron COVID vaccine booster using Pharma-Jet needle-free systems. In addition, the vaccines has been administered using PharmaJet Tropis NFIS.· Portal Instruments, a key player in the needle-free injectors market is focusing on developing needle-free injectors for different chronic ailments and creating awareness regarding painless injections.
*More Insights Available*
FMI, in its new offering, presents an unbiased analysis of the global needle-free injector market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of load (Liquid Injections, Powder Injections, Projectile Injections), technology (Spring-loaded jet injector, Battery-powered jet injector, Gas-powered jet injector), delivery site (Intra dermal injectors, Intramuscular injectors, Subcutaneous injectors), application (Drug Delivery, Vaccines, Cosmetic, Others), end user (Home Care Settings and Long Term Care Centers) across seven major regions (North America, Latin America, Europe, East Asia , South Asia, Oceania and Middle East & Africa)
*Use promo code ->> FMITODAY to get flat 20% discount*
*About the Healthcare Domain at Future Market Insights *
The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
*Table of Content*
*1. Executive Summary*
1.1. Global Market Outlook
1.2. Demand Side and Supply Side Trends
1.3. Technology Roadmap
1.4. Analysis and Recommendations
*2. Market Overview*
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
*3. Key Market Trends*
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
*Get Detailed TOC @* https://www.futuremarketinsights.com/toc/rep-gb-13960
*Have a Look at Related Research Reports of Healthcare*
Contrast Media Injectors Market Size : The global contrast media injectors market was valued at US$ 1.4 Bn in 2021 and is expected to reach US$ 2.4 Bn by 2030, finds Future Market Insights (FMI) in a recent market survey.
Needle-Free Vaccine Injectors Market Growth : Growth in the number of communicable disease due to needle stick injuries is one of the major factors driving the growth of the market.
Wearable Injectors Market Technology : Wearable injectors are drug delivery devices created for single-use wearable device technologies which are designed to deliver large volume drugs to the patients over long durations.
Functional Electrical Stimulation Market Analysis : The global functional electric stimulation market is anticipated to be valued at US$ 600 Million in 2022, forecast a CAGR of 4.1% to be valued at US$ 897 Million from 2022 to 2032.
Gastrointestinal Rare Diseases Treatment Market Forecast : The global gastrointestinal rare diseases treatment market garnered a market value of US$ 1,314.8 Million in 2022 and is expected to accumulate a market value of US$ 1,965 Million by registering a CAGR of 3.7% in the forecast period 2022-2032.
*About Future Market Insights, Inc.*
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
*Contact*:Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
*Enquiries:* sales@futuremarketinsights.com